Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil

Clinical trials have shown the benefits of acetylcholinesterase inhibitors, such as donepezil and galantamine, and an N-methyl-D-aspartate receptor antagonist, memantine, in patients with Alzheimer’s disease (AD). However, little is known regarding the effects of switching from donepezil 5 mg/day to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kano, Osamu, Ito, Hirono, Takazawa, Takanori, Kawase, Yuji, Murata, Kiyoko, Iwamoto, Konosuke, Nagaoka, Tetsuro, Hirayama, Takehisa, Miura, Ken, Nagata, Riya, Kiyozuka, Tetsuhito, Aoyagi, Jo, Sato, Ryuta, Eguchi, Teruo, Ikeda, Ken, Iwasaki, Yasuo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2013
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3575212/
https://ncbi.nlm.nih.gov/pubmed/23431041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S40682
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg